LEEM announces 3rd medicine dialog week

27 July 2008

The French drug industry association, LEEM, has published details of its third week of public dialog about medicines, to be held on October 13-19, with over 100 events taking place across France. The LEEM will be partnered by the national pharmacists union, the ONP, and will have for its theme: My Health, Medication and I.

Christian Lajoux, the LEEM's president, said: "encouraged by the success of previous versions, we have sought this year to listen especially to patients about issues that concern best practice and of clear and useful information about drugs." He added that the appropriate use of pharmaceutical products is a message that is of importance in France today, given concerns about overprescribing and the cost of the national drug bill (Marketletters passim).

The principal themes covered by the various events across France will include: the 10 golden rules for keeping drugs at home; a discussion about making sure that product labeling is comprehensible for patients; the changing expectations of patients in terms of health information, especially for medicines; and the pharmaceutical industry's marketing policies with special reference to relationships with patient groups. The latter theme was added, the LEEM explained, in part to encourage public awareness of the new provisions set out in the European Federation of Pharmaceutical Industries and Associations' Code of Practice, which became effective in France on July 1 (Marketletters passim). A web site established for the week (www.le-medicament-parlons-en.com) will carry news about the events taking place as well as allow the public to discuss and comment on the issues of the week.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight